Bo Wengle

1.5k total citations
45 papers, 1.1k citations indexed

About

Bo Wengle is a scholar working on Pathology and Forensic Medicine, Oncology and Nephrology. According to data from OpenAlex, Bo Wengle has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 10 papers in Nephrology. Recurrent topics in Bo Wengle's work include Vitamin D Research Studies (11 papers), Parathyroid Disorders and Treatments (9 papers) and Bone health and treatments (6 papers). Bo Wengle is often cited by papers focused on Vitamin D Research Studies (11 papers), Parathyroid Disorders and Treatments (9 papers) and Bone health and treatments (6 papers). Bo Wengle collaborates with scholars based in Sweden. Bo Wengle's co-authors include Kjell Hellström, Sver­ker Ljunghall, Lars Lind, T. Christensson, A Alveryd, Henrik Boström, Lars Lööf, Hans Lithell, Leif Wide and Sören Jakobsson and has published in prestigious journals such as PEDIATRICS, Journal of Internal Medicine and Experimental Biology and Medicine.

In The Last Decade

Bo Wengle

44 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Wengle Sweden 19 316 245 238 205 171 45 1.1k
H Schmidt-Gayk Germany 15 323 1.0× 136 0.6× 340 1.4× 118 0.6× 90 0.5× 58 868
Kazutaka Matsushita Japan 16 421 1.3× 65 0.3× 132 0.6× 288 1.4× 117 0.7× 45 974
K. D. G. Edwards Australia 18 274 0.9× 68 0.3× 68 0.3× 253 1.2× 128 0.7× 65 1.1k
F Varga Hungary 18 78 0.2× 239 1.0× 31 0.1× 245 1.2× 90 0.5× 91 1.1k
Stanley E. Bradley United States 18 175 0.6× 156 0.6× 75 0.3× 149 0.7× 262 1.5× 39 1.3k
Takahiro Shoji Japan 12 293 0.9× 47 0.2× 346 1.5× 113 0.6× 189 1.1× 30 854
Przemysław Rutkowski Poland 20 335 1.1× 97 0.4× 47 0.2× 194 0.9× 131 0.8× 76 1.1k
H. W. Seyberth Germany 22 134 0.4× 70 0.3× 42 0.2× 377 1.8× 121 0.7× 55 1.3k
Beate Tiran Austria 20 164 0.5× 44 0.2× 78 0.3× 274 1.3× 206 1.2× 67 1.3k
Charles A. Duncan United States 13 159 0.5× 46 0.2× 53 0.2× 251 1.2× 181 1.1× 26 1.1k

Countries citing papers authored by Bo Wengle

Since Specialization
Citations

This map shows the geographic impact of Bo Wengle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wengle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wengle more than expected).

Fields of papers citing papers by Bo Wengle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Wengle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wengle. The network helps show where Bo Wengle may publish in the future.

Co-authorship network of co-authors of Bo Wengle

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Wengle. A scholar is included among the top collaborators of Bo Wengle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Wengle. Bo Wengle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lind, Lars, Bo Wengle, O. H. Sørensen, & Sver­ker Ljunghall. (2009). Delayed Hypersensitivity in Primary and Secondary Hyperparathyroidism. Treatment with Active Vitamin D. Experimental and Clinical Endocrinology & Diabetes. 95(2). 271–274.
2.
Lind, Lars, Bo Wengle, O. H. Sørensen, & Sver­ker Ljunghall. (2009). Serum Levels of 1,25-(OH)2-Vitamin D are not Altered by Long-Term Supplementation with Alphacalcidol (1-OH-Vitamin D3). Experimental and Clinical Endocrinology & Diabetes. 99(3). 151–153. 1 indexed citations
3.
Lind, Lars, Bo Wengle, Hans Lithell, & Sver­ker Ljunghall. (1992). Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long‐term treatment with active vitamin D (Alphacalcidol). Journal of Internal Medicine. 231(4). 427–432. 10 indexed citations
4.
Lind, Lars, et al.. (1991). Cardiovascular risk factors in primary hyperparathyroidism: a 15‐year follow‐up of operated and unoperated cases. Journal of Internal Medicine. 230(1). 29–35. 44 indexed citations
5.
Lind, Lars, Bo Wengle, Hans Lithell, & Sver­ker Ljunghall. (1991). No Major Metabolic Alterations Accompany the Hypotensive Effect of Active Vitamin D. Upsala Journal of Medical Sciences. 96(3). 199–204. 3 indexed citations
6.
Lind, Lars, Bo Wengle, Hans Lithell, & Sver­ker Ljunghall. (1991). Reduction in Serum Alkaline Phosphatase Levels by Treatment with Active Vitamin D (Alphacalcidol) in Primary and Secondary Hyperparathyroidism and in Euparathyroid Individuals. Scandinavian Journal of Urology and Nephrology. 25(3). 233–236. 4 indexed citations
7.
Lind, Lars, Bo Wengle, Ole Helmer Sørensen, et al.. (1989). Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism. European Journal of Endocrinology. 120(2). 250–256. 14 indexed citations
8.
Lind, Lars, Bo Wengle, Leif Wide, & Sver­ker Ljunghall. (1989). Reduction of Blood Pressure During Long-term Treatment With Active Vitamin D (Alphacalcidol) Is Dependent on Plasma Renin Activity and Calcium Status. American Journal of Hypertension. 2(1). 20–25. 76 indexed citations
9.
Lind, Lars, Sören Jakobsson, Hans Lithell, Bo Wengle, & Sver­ker Ljunghall. (1988). Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease.. BMJ. 297(6654). 960–963. 95 indexed citations
10.
11.
Lind, Lars, et al.. (1988). Suppression of Serum Parathyroid Hormone Levels by Intravenous Alphacalcidol in Uremic Patients on Maintenance Hemodialysis. ˜The œNephron journals/Nephron journals. 48(4). 296–299. 10 indexed citations
12.
Lind, Lars, Bo Wengle, & Sver­ker Ljunghall. (1987). Blood Pressure is Lowered by Vitamin D (Alphacalcidol) during Long‐Term Treatment of Patients with Intermittent Hypercalcaemia. Acta Medica Scandinavica. 222(5). 423–427. 39 indexed citations
13.
Lind, Lars, Bo Wengle, & Sver­ker Ljunghall. (1987). Treatment with Clodronate in Patients with Hypercalcemia Secondary to Malignancy. Upsala Journal of Medical Sciences. 92(3). 259–263. 2 indexed citations
14.
Lööf, Lars & Bo Wengle. (1982). Enzymatic Sulphation of Bile Salts in Man. Scandinavian Journal of Gastroenterology. 17(1). 69–76. 24 indexed citations
15.
Sjögren, I, Bo Wengle, & Magnus Korsgren. (1979). Primary Sclerosing Cholangitis Associated with Fibrosis of the Submandibular Glands and the Pancreas. Acta Medica Scandinavica. 205(1-6). 139–141. 52 indexed citations
16.
Alveryd, A, et al.. (1976). Indications for surgery in the elderly patient with primary hyperparathyroidism.. PubMed. 142(7). 491–4. 19 indexed citations
17.
Boström, Henrik & Bo Wengle. (1969). [Serum calcium screening on admission to the department of internal medicine].. PubMed. 66(46). 4763–8. 4 indexed citations
18.
Boström, Henrik & Bo Wengle. (1967). Studies on ester sulphates. 23. Distribution on phenol and steroid sulphokinase in adult human tissues.. PubMed. 56(4). 691–704. 39 indexed citations
19.
Wengle, Bo. (1966). DISTRIBUTION OF SOME STEROID SULPHOKINASES IN FOETAL HUMAN TISSUES. European Journal of Endocrinology. 52(4). 607–618. 35 indexed citations
20.
Wengle, Bo, Harry Boström, Thomas A. Hamor, et al.. (1962). Studies on Ester Sulphates. 13. On the Enzymic Synthesis of Steroid Disulphates.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 16. 502–504. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Schmidt-Gayk Breakdown of academic impact, for papers by Kazutaka Matsushita Breakdown of academic impact, for papers by K. D. G. Edwards Breakdown of academic impact, for papers by F Varga Breakdown of academic impact, for papers by Stanley E. Bradley Breakdown of academic impact, for papers by Takahiro Shoji Breakdown of academic impact, for papers by Przemysław Rutkowski Breakdown of academic impact, for papers by H. W. Seyberth Breakdown of academic impact, for papers by Beate Tiran Breakdown of academic impact, for papers by Charles A. Duncan
Rankless by CCL
2026